TrialFrontiers in endocrinology2024

Distinct effects of rosuvastatin and rosuvastatin/ezetimibe on senescence markers of CD8+ T cells in patients with type 2 diabetes mellitus: a randomized controlled trial.

Sang-Hyeon Ju et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.